CCR5 Expression and Immune System Signalling
Post# of 152327
(Total Views: 242)
Posted On: 05/06/2025 12:50:44 AM
I love ChatGPT! So patient, answers my questions, one after the other.
CCR5 Expression and Immune System Signalling
You asked:
Tell me about the abundance or lack thereof of CCR5 chemokine receptors on human cell types and why the variance and what causes expression changes.
ChatGPT said:
CCR5 (C-C chemokine receptor type 5) is a G protein-coupled receptor expressed on the surface of various immune cells, and its expression levels vary significantly depending on cell type, activation state, genetic background, and environmental stimuli. Here’s a breakdown of its abundance and regulation:
Cell Types and CCR5 Expression:
High to Moderate Expression:
Memory and activated T cells (especially CD4+ T cells): CCR5 is primarily expressed on Th1-type CD4+ memory T cells, which are involved in inflammatory responses.
Macrophages and monocytes: Often express CCR5, particularly during inflammation or infection.
Dendritic cells: Express CCR5 under certain conditions, especially immature DCs.
Microglia: The brain’s resident immune cells can express CCR5, relevant to neuroinflammation.
Low or Absent Expression:
Naïve T cells: Generally low or no CCR5 expression.
B cells: Typically do not express CCR5.
Epithelial and endothelial cells: Usually CCR5-negative, though some pathological conditions can induce expression.
Why the Variance in CCR5 Expression?
Several factors control CCR5 expression:
1. Activation State of the Cell
T cells and macrophages upregulate CCR5 in response to inflammatory cytokines (e.g., IL-2, IL-12, IFN-γ).
Naïve T cells typically lack CCR5, but upon activation and differentiation (especially toward a Th1 phenotype), CCR5 is induced.
2. Genetic Polymorphisms
CCR5-Δ32 mutation (a 32-bp deletion in the CCR5 gene) leads to a non-functional receptor. Homozygotes are resistant to CCR5-tropic HIV-1 infection; heterozygotes have reduced surface expression.
Promoter polymorphisms also influence transcription efficiency and receptor density.
3. Cytokine Milieu
Certain cytokines (e.g., TNF-α, IL-1β) increase CCR5 expression.
Others (like IL-10) may downregulate it indirectly via anti-inflammatory pathways.
4. Epigenetic Regulation
DNA methylation and histone modifications at the CCR5 promoter influence its transcription.
Environmental or pathological conditions (e.g., chronic infections, autoimmune disease) can modulate this.
5. Viral Infections and Immune Status
Chronic infections (like HIV, EBV, CMV) can modulate CCR5 expression either directly (via viral proteins) or indirectly (via chronic immune activation).
CCR5 serves as a co-receptor for HIV-1 entry, so expression levels critically influence infection susceptibility.
Functional Implications of CCR5 Expression:
HIV-1 infection: CCR5 is a coreceptor for viral entry. Lower expression or lack of CCR5 (e.g., Δ32 homozygosity) confers resistance.
Autoimmune and inflammatory diseases: High CCR5 expression correlates with enhanced migration of immune cells to inflammation sites (e.g., in MS, RA).
Cancer: CCR5 is implicated in tumor cell migration and metastasis in some cancers.
Therapeutics: CCR5 antagonists like maraviroc are used in HIV therapy and being explored for inflammatory and neurodegenerative disorders.
You said:
CCR5 responds to CCL5 signalling, of course, but what and when do cells send out CCL5 signalling and why does the signalling get out of balance sometimes and cause Cytokine Storm?
ChatGPT said:
You're absolutely right — CCR5 is a receptor for CCL5 (also known as RANTES) and several other chemokines (e.g., CCL3/MIP-1α, CCL4/MIP-1β). Understanding when and why CCL5 is produced — and how it contributes to immune balance or overreaction — is key to grasping its role in both normal immunity and pathological states like cytokine storms.
???? What Produces CCL5 and When?
Cell Types That Produce CCL5:
T cells (especially activated CD8+ and Th1 CD4+)
Macrophages and monocytes
Natural killer (NK) cells
Platelets
Dendritic cells
Fibroblasts, epithelial, and endothelial cells (especially under stress/injury)
Triggers for CCL5 Production:
Proinflammatory cytokines: IL-1β, TNF-α, IFN-γ
Pattern recognition receptor activation: Like Toll-like receptors (TLRs) upon recognizing pathogens (e.g., viral RNA, bacterial components)
Cell damage or viral infection: Particularly viral infections like HIV, influenza, SARS-CoV-2
When is CCL5 Produced?
During early innate immune responses to pathogens
In adaptive immunity, following T cell activation
In chronic inflammation or autoimmune disease, where immune cells are persistently activated
???? Why Do Cells Produce CCL5?
CCL5 acts as a chemoattractant. Its primary roles are:
Recruiting leukocytes: Especially CCR5-expressing cells like memory/effector T cells, macrophages, and NK cells to the site of infection/inflammation
Enhancing immune cell adhesion to endothelium
Supporting cytotoxic responses via CD8+ T cells and NK cells
Promoting Th1 responses (anti-viral, anti-tumor immunity)
So essentially, CCL5 serves as a homing signal: “Here’s where the fight is — come help.”
???? How Does CCL5/CCR5 Signaling Contribute to Cytokine Storms?
A cytokine storm is a hyperinflammatory state where the immune system goes into overdrive, causing tissue damage. CCL5/CCR5 is often involved in this amplification loop.
Why It Goes Out of Balance:
Massive innate immune activation:
Viral PAMPs (pathogen-associated molecular patterns) trigger macrophages and DCs to produce TNF-α, IL-6, IL-1β, and CCL5.
CCL5 recruits more immune cells → they produce more cytokines and chemokines, including more CCL5.
Positive feedback loop:
CCR5+ T cells and monocytes migrate in and get re-activated, releasing further cytokines.
This creates a loop of sustained immune activation that fails to resolve.
Failure to regulate inflammation:
Normally, Tregs and anti-inflammatory cytokines (IL-10, TGF-β) dampen responses.
In a cytokine storm, these brakes are ineffective or too late.
Viral hijacking:
Viruses like SARS-CoV-2 can directly induce high levels of CCL5.
In COVID-19, high serum CCL5 correlates with lung injury and mortality.
In HIV, CCL5 can paradoxically both help contain the virus and enhance disease progression by recruiting more susceptible cells.
???? Therapeutic Targeting of CCL5/CCR5
CCR5 antagonists (e.g., maraviroc) are being repurposed not just for HIV, but for COVID-19, GVHD, and even cancer.
Blocking CCR5 in cytokine storms can reduce immune cell trafficking and tissue damage — dampening the fire without totally shutting off immunity.
Summary
Component Function Effect When Dysregulated
CCL5 (RANTES) Attracts immune cells via CCR5 Exacerbates inflammation and tissue damage
CCR5 Receptor for CCL5 on T cells, macrophages Promotes immune cell migration and activation
Overactivation Excess CCL5/CCR5 signaling Can drive cytokine storm, immune pathology
You said:
Does a high level of CCL5 signalling cause higher expression of CCR5 receptors on immune cells?
ChatGPT said:
Great question — the relationship between CCL5 (RANTES) levels and CCR5 expression on immune cells is not straightforwardly linear. In fact, high levels of CCL5 do not necessarily cause increased CCR5 expression. Instead, chronic or excessive CCL5 signaling can often lead to the opposite: CCR5 downregulation or desensitization.
???? What Actually Happens When CCL5 Levels Are High?
1. Short-Term Exposure: Activation & Stabilization
In early or moderate immune activation, CCL5 binding to CCR5 can stabilize or upregulate CCR5 on the cell surface by promoting immune cell activation and differentiation (especially Th1-type CD4+ T cells).
This can reinforce immune cell migration and tissue homing during acute inflammation.
2. Prolonged or High-Level Exposure: Downregulation
Chronic or excessive CCL5 exposure (e.g., in chronic infection or cytokine storm) leads to:
Internalization of CCR5 via receptor-ligand binding.
Desensitization through phosphorylation of the receptor (via G-protein receptor kinases).
Degradation or recycling of the receptor, depending on cell state.
✅ So: Persistent high CCL5 → less surface CCR5 over time.
3. Feedback Inhibition
This acts as a regulatory mechanism to prevent over-recruitment of CCR5+ cells and avoid immune overactivation.
But in pathologic states, it can also impair immune cell responsiveness or shift trafficking patterns.
???? Factors That Do Increase CCR5 Expression:
Cytokines like IL-2, IL-12, and IFN-γ
Viral infections (e.g., CMV, EBV) that cause T cell activation
TLR agonists or bacterial PAMPs
Epigenetic remodeling during T cell differentiation (especially Th1 skewing)
These factors tend to upregulate CCR5 mRNA and surface expression, often independently of CCL5.
???? Clinical Relevance
In HIV infection, early stages may show increased CCR5 expression due to T cell activation — but over time, high CCL5 can lead to CCR5 internalization, which may offer some protection against further infection.
In cytokine storms or autoimmune conditions, the high CCL5/low CCR5 dynamic may reflect receptor exhaustion, not active enhancement.
???? Summary:
Condition Effect on CCR5 Expression
Low/moderate CCL5 May stabilize/increase CCR5 in early immune response
High/sustained CCL5 Causes CCR5 internalization and downregulation
Inflammatory cytokines (IL-2, IFN-γ) Upregulate CCR5 expression
Chronic inflammation Often leads to CCR5 desensitization
???? Technical Terms & Definitions – CCR5/CCL5 and Immune Regulation
???? Immunological Terms and Concepts
CCR5 (C-C chemokine receptor type 5)
A receptor on immune cells (e.g., T cells, macrophages) that binds certain chemokines like CCL5 to guide immune cell migration.
CCL5 (RANTES)
A chemokine that recruits immune cells to sites of inflammation and infection by binding to CCR5 and other receptors.
Chemokine
A type of signaling protein that guides the movement of immune cells toward sites needing immune defense.
Cytokine
A general term for signaling proteins that coordinate immune and inflammatory responses.
Cytokine storm
An excessive immune reaction characterized by overwhelming cytokine release, often leading to tissue damage.
Chemoattractant
A molecule that attracts cells (especially immune cells) via a concentration gradient.
T cells (CD4+, CD8+)
Lymphocytes involved in adaptive immunity; CD4+ help coordinate responses, CD8+ kill infected or cancerous cells.
Th1 cells
A subtype of CD4+ T cells that enhance immune responses against viruses and intracellular bacteria.
Tregs (Regulatory T cells)
T cells that suppress immune activity to prevent autoimmunity and resolve inflammation.
Monocytes/Macrophages
White blood cells that detect, engulf, and destroy pathogens; macrophages are the tissue form of monocytes.
Dendritic cells (DCs)
Immune cells that present antigens to T cells to initiate adaptive immune responses.
Natural Killer (NK) cells
Innate immune cells that kill virally infected or tumor cells without prior sensitization.
Microglia
Immune cells of the central nervous system, functionally similar to macrophages.
Memory T cells
T cells that persist long-term after infection to provide faster responses upon re-exposure.
???? Molecular and Genetic Terms
Receptor internalization
The process where receptors are pulled into the cell after being activated, reducing surface expression.
Desensitization (of receptors)
A process where continuous stimulation reduces receptor activity or surface presence.
Epigenetic regulation
Modifications to gene expression that do not alter DNA sequence (e.g., DNA methylation, histone changes).
Transcription
The process of converting DNA into RNA, the first step in protein production.
CCR5-Δ32 mutation
A genetic deletion that leads to a nonfunctional CCR5 receptor, conferring resistance to certain HIV strains.
Promoter region
A DNA sequence that controls the initiation of gene transcription.
TLR (Toll-like receptor)
Receptors that detect microbial patterns (PAMPs) and trigger innate immune responses.
PAMPs (Pathogen-associated molecular patterns)
Molecular signatures found on pathogens that are recognized by the immune system.
???? Clinical and Pharmacological Terms
Maraviroc
A CCR5 antagonist used in HIV therapy and studied in immune overactivation conditions like cytokine storms.
Coreceptor
A secondary receptor (like CCR5) that aids in viral entry into host cells.
Immune trafficking
The guided movement of immune cells throughout the body in response to chemokines.
Positive feedback loop
A cycle where an output stimulates more of the same output, potentially causing runaway responses.
Desensitization loop
A mechanism that turns down receptor signaling during prolonged stimulation to prevent overreaction.
CCR5 Expression and Immune System Signalling
You asked:
Tell me about the abundance or lack thereof of CCR5 chemokine receptors on human cell types and why the variance and what causes expression changes.
ChatGPT said:
CCR5 (C-C chemokine receptor type 5) is a G protein-coupled receptor expressed on the surface of various immune cells, and its expression levels vary significantly depending on cell type, activation state, genetic background, and environmental stimuli. Here’s a breakdown of its abundance and regulation:
Cell Types and CCR5 Expression:
High to Moderate Expression:
Memory and activated T cells (especially CD4+ T cells): CCR5 is primarily expressed on Th1-type CD4+ memory T cells, which are involved in inflammatory responses.
Macrophages and monocytes: Often express CCR5, particularly during inflammation or infection.
Dendritic cells: Express CCR5 under certain conditions, especially immature DCs.
Microglia: The brain’s resident immune cells can express CCR5, relevant to neuroinflammation.
Low or Absent Expression:
Naïve T cells: Generally low or no CCR5 expression.
B cells: Typically do not express CCR5.
Epithelial and endothelial cells: Usually CCR5-negative, though some pathological conditions can induce expression.
Why the Variance in CCR5 Expression?
Several factors control CCR5 expression:
1. Activation State of the Cell
T cells and macrophages upregulate CCR5 in response to inflammatory cytokines (e.g., IL-2, IL-12, IFN-γ).
Naïve T cells typically lack CCR5, but upon activation and differentiation (especially toward a Th1 phenotype), CCR5 is induced.
2. Genetic Polymorphisms
CCR5-Δ32 mutation (a 32-bp deletion in the CCR5 gene) leads to a non-functional receptor. Homozygotes are resistant to CCR5-tropic HIV-1 infection; heterozygotes have reduced surface expression.
Promoter polymorphisms also influence transcription efficiency and receptor density.
3. Cytokine Milieu
Certain cytokines (e.g., TNF-α, IL-1β) increase CCR5 expression.
Others (like IL-10) may downregulate it indirectly via anti-inflammatory pathways.
4. Epigenetic Regulation
DNA methylation and histone modifications at the CCR5 promoter influence its transcription.
Environmental or pathological conditions (e.g., chronic infections, autoimmune disease) can modulate this.
5. Viral Infections and Immune Status
Chronic infections (like HIV, EBV, CMV) can modulate CCR5 expression either directly (via viral proteins) or indirectly (via chronic immune activation).
CCR5 serves as a co-receptor for HIV-1 entry, so expression levels critically influence infection susceptibility.
Functional Implications of CCR5 Expression:
HIV-1 infection: CCR5 is a coreceptor for viral entry. Lower expression or lack of CCR5 (e.g., Δ32 homozygosity) confers resistance.
Autoimmune and inflammatory diseases: High CCR5 expression correlates with enhanced migration of immune cells to inflammation sites (e.g., in MS, RA).
Cancer: CCR5 is implicated in tumor cell migration and metastasis in some cancers.
Therapeutics: CCR5 antagonists like maraviroc are used in HIV therapy and being explored for inflammatory and neurodegenerative disorders.
You said:
CCR5 responds to CCL5 signalling, of course, but what and when do cells send out CCL5 signalling and why does the signalling get out of balance sometimes and cause Cytokine Storm?
ChatGPT said:
You're absolutely right — CCR5 is a receptor for CCL5 (also known as RANTES) and several other chemokines (e.g., CCL3/MIP-1α, CCL4/MIP-1β). Understanding when and why CCL5 is produced — and how it contributes to immune balance or overreaction — is key to grasping its role in both normal immunity and pathological states like cytokine storms.
???? What Produces CCL5 and When?
Cell Types That Produce CCL5:
T cells (especially activated CD8+ and Th1 CD4+)
Macrophages and monocytes
Natural killer (NK) cells
Platelets
Dendritic cells
Fibroblasts, epithelial, and endothelial cells (especially under stress/injury)
Triggers for CCL5 Production:
Proinflammatory cytokines: IL-1β, TNF-α, IFN-γ
Pattern recognition receptor activation: Like Toll-like receptors (TLRs) upon recognizing pathogens (e.g., viral RNA, bacterial components)
Cell damage or viral infection: Particularly viral infections like HIV, influenza, SARS-CoV-2
When is CCL5 Produced?
During early innate immune responses to pathogens
In adaptive immunity, following T cell activation
In chronic inflammation or autoimmune disease, where immune cells are persistently activated
???? Why Do Cells Produce CCL5?
CCL5 acts as a chemoattractant. Its primary roles are:
Recruiting leukocytes: Especially CCR5-expressing cells like memory/effector T cells, macrophages, and NK cells to the site of infection/inflammation
Enhancing immune cell adhesion to endothelium
Supporting cytotoxic responses via CD8+ T cells and NK cells
Promoting Th1 responses (anti-viral, anti-tumor immunity)
So essentially, CCL5 serves as a homing signal: “Here’s where the fight is — come help.”
???? How Does CCL5/CCR5 Signaling Contribute to Cytokine Storms?
A cytokine storm is a hyperinflammatory state where the immune system goes into overdrive, causing tissue damage. CCL5/CCR5 is often involved in this amplification loop.
Why It Goes Out of Balance:
Massive innate immune activation:
Viral PAMPs (pathogen-associated molecular patterns) trigger macrophages and DCs to produce TNF-α, IL-6, IL-1β, and CCL5.
CCL5 recruits more immune cells → they produce more cytokines and chemokines, including more CCL5.
Positive feedback loop:
CCR5+ T cells and monocytes migrate in and get re-activated, releasing further cytokines.
This creates a loop of sustained immune activation that fails to resolve.
Failure to regulate inflammation:
Normally, Tregs and anti-inflammatory cytokines (IL-10, TGF-β) dampen responses.
In a cytokine storm, these brakes are ineffective or too late.
Viral hijacking:
Viruses like SARS-CoV-2 can directly induce high levels of CCL5.
In COVID-19, high serum CCL5 correlates with lung injury and mortality.
In HIV, CCL5 can paradoxically both help contain the virus and enhance disease progression by recruiting more susceptible cells.
???? Therapeutic Targeting of CCL5/CCR5
CCR5 antagonists (e.g., maraviroc) are being repurposed not just for HIV, but for COVID-19, GVHD, and even cancer.
Blocking CCR5 in cytokine storms can reduce immune cell trafficking and tissue damage — dampening the fire without totally shutting off immunity.
Summary
Component Function Effect When Dysregulated
CCL5 (RANTES) Attracts immune cells via CCR5 Exacerbates inflammation and tissue damage
CCR5 Receptor for CCL5 on T cells, macrophages Promotes immune cell migration and activation
Overactivation Excess CCL5/CCR5 signaling Can drive cytokine storm, immune pathology
You said:
Does a high level of CCL5 signalling cause higher expression of CCR5 receptors on immune cells?
ChatGPT said:
Great question — the relationship between CCL5 (RANTES) levels and CCR5 expression on immune cells is not straightforwardly linear. In fact, high levels of CCL5 do not necessarily cause increased CCR5 expression. Instead, chronic or excessive CCL5 signaling can often lead to the opposite: CCR5 downregulation or desensitization.
???? What Actually Happens When CCL5 Levels Are High?
1. Short-Term Exposure: Activation & Stabilization
In early or moderate immune activation, CCL5 binding to CCR5 can stabilize or upregulate CCR5 on the cell surface by promoting immune cell activation and differentiation (especially Th1-type CD4+ T cells).
This can reinforce immune cell migration and tissue homing during acute inflammation.
2. Prolonged or High-Level Exposure: Downregulation
Chronic or excessive CCL5 exposure (e.g., in chronic infection or cytokine storm) leads to:
Internalization of CCR5 via receptor-ligand binding.
Desensitization through phosphorylation of the receptor (via G-protein receptor kinases).
Degradation or recycling of the receptor, depending on cell state.
✅ So: Persistent high CCL5 → less surface CCR5 over time.
3. Feedback Inhibition
This acts as a regulatory mechanism to prevent over-recruitment of CCR5+ cells and avoid immune overactivation.
But in pathologic states, it can also impair immune cell responsiveness or shift trafficking patterns.
???? Factors That Do Increase CCR5 Expression:
Cytokines like IL-2, IL-12, and IFN-γ
Viral infections (e.g., CMV, EBV) that cause T cell activation
TLR agonists or bacterial PAMPs
Epigenetic remodeling during T cell differentiation (especially Th1 skewing)
These factors tend to upregulate CCR5 mRNA and surface expression, often independently of CCL5.
???? Clinical Relevance
In HIV infection, early stages may show increased CCR5 expression due to T cell activation — but over time, high CCL5 can lead to CCR5 internalization, which may offer some protection against further infection.
In cytokine storms or autoimmune conditions, the high CCL5/low CCR5 dynamic may reflect receptor exhaustion, not active enhancement.
???? Summary:
Condition Effect on CCR5 Expression
Low/moderate CCL5 May stabilize/increase CCR5 in early immune response
High/sustained CCL5 Causes CCR5 internalization and downregulation
Inflammatory cytokines (IL-2, IFN-γ) Upregulate CCR5 expression
Chronic inflammation Often leads to CCR5 desensitization
???? Technical Terms & Definitions – CCR5/CCL5 and Immune Regulation
???? Immunological Terms and Concepts
CCR5 (C-C chemokine receptor type 5)
A receptor on immune cells (e.g., T cells, macrophages) that binds certain chemokines like CCL5 to guide immune cell migration.
CCL5 (RANTES)
A chemokine that recruits immune cells to sites of inflammation and infection by binding to CCR5 and other receptors.
Chemokine
A type of signaling protein that guides the movement of immune cells toward sites needing immune defense.
Cytokine
A general term for signaling proteins that coordinate immune and inflammatory responses.
Cytokine storm
An excessive immune reaction characterized by overwhelming cytokine release, often leading to tissue damage.
Chemoattractant
A molecule that attracts cells (especially immune cells) via a concentration gradient.
T cells (CD4+, CD8+)
Lymphocytes involved in adaptive immunity; CD4+ help coordinate responses, CD8+ kill infected or cancerous cells.
Th1 cells
A subtype of CD4+ T cells that enhance immune responses against viruses and intracellular bacteria.
Tregs (Regulatory T cells)
T cells that suppress immune activity to prevent autoimmunity and resolve inflammation.
Monocytes/Macrophages
White blood cells that detect, engulf, and destroy pathogens; macrophages are the tissue form of monocytes.
Dendritic cells (DCs)
Immune cells that present antigens to T cells to initiate adaptive immune responses.
Natural Killer (NK) cells
Innate immune cells that kill virally infected or tumor cells without prior sensitization.
Microglia
Immune cells of the central nervous system, functionally similar to macrophages.
Memory T cells
T cells that persist long-term after infection to provide faster responses upon re-exposure.
???? Molecular and Genetic Terms
Receptor internalization
The process where receptors are pulled into the cell after being activated, reducing surface expression.
Desensitization (of receptors)
A process where continuous stimulation reduces receptor activity or surface presence.
Epigenetic regulation
Modifications to gene expression that do not alter DNA sequence (e.g., DNA methylation, histone changes).
Transcription
The process of converting DNA into RNA, the first step in protein production.
CCR5-Δ32 mutation
A genetic deletion that leads to a nonfunctional CCR5 receptor, conferring resistance to certain HIV strains.
Promoter region
A DNA sequence that controls the initiation of gene transcription.
TLR (Toll-like receptor)
Receptors that detect microbial patterns (PAMPs) and trigger innate immune responses.
PAMPs (Pathogen-associated molecular patterns)
Molecular signatures found on pathogens that are recognized by the immune system.
???? Clinical and Pharmacological Terms
Maraviroc
A CCR5 antagonist used in HIV therapy and studied in immune overactivation conditions like cytokine storms.
Coreceptor
A secondary receptor (like CCR5) that aids in viral entry into host cells.
Immune trafficking
The guided movement of immune cells throughout the body in response to chemokines.
Positive feedback loop
A cycle where an output stimulates more of the same output, potentially causing runaway responses.
Desensitization loop
A mechanism that turns down receptor signaling during prolonged stimulation to prevent overreaction.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼